Search results
Results From The WOW.Com Content Network
Aliskiren/hydrochlorothiazide, sold under the brand name Tekturna HCT among others, is a fixed-dose combination medication for the treatment of hypertension (high blood pressure).
Hydrochlorothiazide, sold under the brand name Hydrodiuril among others, is a diuretic medication used to treat hypertension and swelling due to fluid build-up. [4] Other uses include treating diabetes insipidus and renal tubular acidosis and to decrease the risk of kidney stones in those with a high calcium level in the urine . [ 4 ]
Template:Drugs for functional gastrointestinal disorders; Template:Drugs for obstructive airway diseases; Template:Drugs for peptic ulcer and GORD; Template:Drugs for treatment of bone diseases; Template:Drugs for treatment of hyperkalemia and hyperphosphatemia; Template:Drugs used in benign prostatic hypertrophy
Olmesartan works by blocking the effects of angiotensin II while hydrochlorothiazide works by increasing the loss of sodium by the kidneys. [1] No generic version is available in the United States as of 2017. [2] In 2022, it was the 235th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [4] [5]
Most of the drug excreted is unchanged, only small portion of the drug is metabolized to its inactive form 4-hydroxyvaleryl valsartan, the enzyme suspected to be responsible for this is the liver enzyme CYP2C9. [18] Hydrochlorothiazide has an oral bioavailability of 70% and reaches peak concentration around 1.5–2 hours following ingestion.
[[Category:Medication templates]] to the <includeonly> section at the bottom of that page. Otherwise, add <noinclude>[[Category:Medication templates]]</noinclude> to the end of the template code, making sure it starts on the same line as the code's last character.
[2] [3] It decreases blood pressure mainly by hydrochlorothiazide while triamterene decreases the amount of potassium lost. [2] [3] The combination was approved for medical use in the United States in 1965. [5] In 2022, it was the 116th most commonly prescribed medication in the United States, with more than 5 million prescriptions. [6] [7]
"FDA Drug Safety Communication: New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)". U.S. Food and Drug Administration (FDA) . 29 June 2021. v